GeoVax (GOVX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
GeoVax Labs, Inc. (GOVX) relies on patent protection for its developments and stringent FDA requirements, which block new entrants. A diversified portfolio of cancer and viral vaccines minimizes the probability of research failure. This chart illustrates that the asset's market value relative to EBITDA is 0.00. However, the company is competing for funding against global behemoths amid fierce rivalry for government support.
geovax.com - analytical breakdowns and key metrics (GOVX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
GOVX - Company Net Income|Future Profit GeoVax Labs, Inc.|GOVX - Price to Earnings Ratio|Forward P/E Multiple GeoVax Labs, Inc.|GOVX - PEG Multiple|Enterprise Value to EBITDA Ratio GeoVax Corp|GOVX - Operating profit before amortization|Net earnings per share for the last 12 months GeoVax|GOVX - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months geovax.com|GOVX - Earnings per share growth in current year|Earnings growth forecast for next year GeoVax Labs, Inc.
- sales and revenue data:
Initial company analysis:GeoVax Labs Inc GOVX
When selecting defensive assets, assessing business value relative to operating profit and net debt is critical. For GeoVax Labs, Inc. (GOVX), which depends on external financing and clinical trial risks, the company's EV/EBITDA ratio in a historical context allows investors to separate market speculation from fundamental value by measuring the enterprise's payback period, accounting for all debt obligations and capitalization.
Main competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Dianthus Corp (DNTH)|PHVS: EV/EBITDA Multiple|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Company Value to EBITDA Precigen Inc PGEN|Enterprise Value to EBITDA Ratio PHAR (Pharming)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NKTR (Nektar Corp)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM: Enterprise Value to EBITDA Ratio|GOSS (Gossamer Bio Inc) - Enterprise Value to Operating Income Before Depreciation|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SVRA|EV/EBITDA Multiple RIGL|EV/EBITDA Multiple AnaptysBio Inc (ANAB)|EV/EBITDA Multiple ATXS (Astria Pharma)|enGene Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|Kyverna Therapeutics Inc. - Business Value to Operating Income Before Depreciation|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|theratech.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|ELDN - Enterprise Value to EBITDA Ratio|AGEN: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Climb Bio, Inc CLYM|ZURA: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple atyrpharma.com ATYR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|Company Value to EBITDA Ikena Oncology, Inc. IMA|Enterprise Value to EBITDA Ratio STTK (Shattuck Labs, Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization EQ (equilliumbio.com)|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|IMUX: Enterprise Value to Operating Income Before Depreciation|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IFRX|XFOR: EV/EBITDA Multiple|Adicet Bio, Inc. - Business Value to Operating Income Before Depreciation|CELU (Celularity Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple inmunebio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Barinthus Biotherapeutics plc (BRNS)|KZR (Kezar Life Sciences Inc.) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX - Enterprise Value to EBITDA Ratio|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|QTTB - EV/EBITDA Multiple|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc - Business Value to Operating Income Before Depreciation|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|XTL Bio (XTLB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM - Enterprise Value to EBITDA Ratio|ADTX: Enterprise Value to EBITDA Ratio|GRI - EV/EBITDA Multiple|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation HIND|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Indaptus Therapeutics Inc INDP|EV/EBITDA Multiple SCNI|calcimedica.com (CALI) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Company Value to EBITDA|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA IGM Biosciences, Inc.|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
